retatrutide clinical studies ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide clinical trial done! Now
Description
Stewart with a surprising announcement before diving into a conversation about the trending topic of GLP-1 Medications
While cross-trial comparisons should always be interpreted cautiously, these results appear to exceed what weve previously seen with semaglutide and tirzepatide alone
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), initially developed for diabetes and obesity, exhibit pleiotropic effectsincluding anti-inflammatory, ...
A massive new study shows GLP-1 drugs like semaglutide don't just help with weight and blood sugar
Results Seven trials (6609 participants) were included
